# PAR (PAR)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹92.27
Day Change: +6.82%
52W High: ₹122.43
52W Low: ₹78.05
Market Cap: ₹107 Cr

## Valuation
P/E: 7.72
P/B: 1.01
EPS: ₹11.3
Book Value: ₹86.6
Dividend Yield: 0%

## Returns
1Y Return: -17.75%

## Profitability
ROE: 0%
ROCE: 25.85%
Debt/Equity: 0
Revenue Growth: 37.2%
Profit Growth: 729.8%
EBITDA Margin: 17.14%
Operating Margin: 17.49%

## About
PAR is a Pharma company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: PAR makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Pharma. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Closure of Trading Window
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-25T14:00:11.436Z
Price History Updated: 2026-05-25T05:24:13.429Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:13.429Z
Quant Updated: 2026-05-25T05:24:13.429Z
Sentiment Updated: 2026-05-25T05:24:13.429Z
Financials Status: current
Financials Updated: 2026-05-18T13:30:00.909Z
Financials Last Attempt: 2026-05-18T13:30:00.909Z
Financials Provider Tried: database
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹100.55 Cr
Operating Profit: ₹15.67 Cr (OPM 15.58%)
Net Profit: ₹13.36 Cr
Tax: ₹4.57 Cr

## Annual P&L History
FY25: Rev ₹100.55Cr | PAT ₹13.36Cr | OPM 15.58%
FY24: Rev ₹95.11Cr | PAT ₹14.5Cr | OPM 21.2%
FY23: Rev ₹95.1Cr | PAT ₹11.33Cr | OPM 15.31%

## Balance Sheet (FY25)
Total Assets: ₹119.39 Cr
Total Liabilities: ₹20.42 Cr
Borrowings: ₹0 Cr
Cash: ₹27.58 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Falgun Vallabhbhai Savani, Chairman of the Board & MD
- Jignesh Vallabhbhai Savani, CEO & Executive Director
- Chintan Pratapbhai Chauhan, Chief Financial Officer
- Sanket Bhupendrabhai Trivedi, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/par
Disclaimer: For research and education only. Not investment advice.